Search research articles
Contact Us
Filters
Showing results (91-100 of 147) with videos related to
Page
of 15
Sort By:
Thrombosis and Haemostasis
|
August 5, 2016
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y<sub>12</sub> receptor inhibitors
Fabiana Rollini, Francesco Franchi, Kamaldeep Singh, et al.
JACC. Cardiovascular Interventions
|
November 5, 2021
Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor
Francesco Franchi, Fabiana Rollini, Mattia Galli, et al.
Thrombosis and Haemostasis
|
December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study
Francesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Journal of the American College of Cardiology
|
September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease
Dominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
JACC. Cardiovascular Interventions
|
June 29, 2015
Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation
Jung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
JACC. Cardiovascular Interventions
|
September 26, 2015
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation
Francesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
JACC. Cardiovascular Interventions
|
March 18, 2014
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients
Fabiana Rollini, Francesco Franchi, Antonio Tello-Montoliu, et al.
Journal of the American Heart Association
|
March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
Francesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Clinical Pharmacology and Therapeutics
|
July 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, et al.
Journal of the American College of Cardiology
|
March 26, 2016
Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study
Fabiana Rollini, Francesco Franchi, Jenny Hu, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 147) with videos related to
Sort By:
Page
of 15
Thrombosis and Haemostasis
|
August 5, 2016
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y<sub>12</sub> receptor inhibitors
Fabiana Rollini, Francesco Franchi, Kamaldeep Singh, et al.
JACC. Cardiovascular Interventions
|
November 5, 2021
Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor
Francesco Franchi, Fabiana Rollini, Mattia Galli, et al.
Thrombosis and Haemostasis
|
December 4, 2015
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study
Francesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
Journal of the American College of Cardiology
|
September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease
Dominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
JACC. Cardiovascular Interventions
|
June 29, 2015
Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation
Jung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
JACC. Cardiovascular Interventions
|
September 26, 2015
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation
Francesco Franchi, Fabiana Rollini, Jung Rae Cho, et al.
JACC. Cardiovascular Interventions
|
March 18, 2014
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients
Fabiana Rollini, Francesco Franchi, Antonio Tello-Montoliu, et al.
Journal of the American Heart Association
|
March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial
Francesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Clinical Pharmacology and Therapeutics
|
July 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, et al.
Journal of the American College of Cardiology
|
March 26, 2016
Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study
Fabiana Rollini, Francesco Franchi, Jenny Hu, et al.
Page
of 15